Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Century Therapeutics Inc’s stock clocked out at $0.53, down -5.54% from its previous closing price of $0.56. In other words, the price has decreased by -$5.54 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
To gain a deeper understanding of IPSC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Farid Adrienne bought 1,024 shares for $0.55 per share.
Pfeiffenberger Brent sold 2,235 shares of IPSC for $1,375 on Mar 10 ’25. The President and CEO now owns 1,190,310 shares after completing the transaction at $0.61 per share. On Mar 10 ’25, another insider, Russotti Gregory, who serves as the insider of the company, sold 2,360 shares for $0.61 each. As a result, the insider received 1,451 and left with 272,573 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.93 while its Price-to-Book (P/B) ratio in mrq is 0.28.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $3.70, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be -55.18%.
Shares Statistics:
A total of 85.84M shares are outstanding, with a floating share count of 38.89M. Insiders hold about 54.86% of the company’s shares, while institutions hold 34.90% stake in the company.
